Madrigal Pharmaceuticals, Inc. Stock Deutsche Boerse AG
Stocks
YDO1
US5588681057
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 449.50 EUR | +0.63% |
|
+3.40% | -9.23% |
| Market Cap | 11.85B 10.43B 9.6B 8.98B 16.82B 1,118B 17.16B 115B 44.58B 551B 44.48B 43.5B 1,917B | P/E 2026 * |
-74.8x | P/E 2027 * | 51.5x |
|---|---|---|---|---|---|
| Enterprise Value | 11.32B 9.96B 9.17B 8.58B 16.07B 1,068B 16.39B 110B 42.59B 527B 42.49B 41.56B 1,831B | EV / Sales 2026 * |
7.57x | EV / Sales 2027 * | 4.87x |
| Free-Float |
94.32% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Madrigal Pharmaceuticals, Inc.
| 1 day | +0.63% | ||
| 1 week | +3.40% | ||
| Current month | +5.59% | ||
| 1 month | +0.78% | ||
| 3 months | +17.58% | ||
| 6 months | -11.79% | ||
| Current year | -9.23% |
| 1 week | 435.5 |  | 456.6 |
| 1 month | 384.8 | | 460.9 |
| Current year | 354 | | 506.4 |
| 1 year | 235.7 | | 523.2 |
| 3 years | 112.6 | | 523.2 |
| 5 years | 47 | | 523.2 |
| 10 years | 0.26 | | 523.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
William Sibold
CEO | Chief Executive Officer | 59 | 2023-09-07 |
Mardi Dier
DFI | Director of Finance/CFO | 62 | 2024-03-10 |
David Soergel
CTO | Chief Tech/Sci/R&D Officer | 58 | 2025-04-20 |
| Director | Title | Age | Since |
|---|---|---|---|
Paul Friedman
CHM | Chairman | 83 | 2016-07-21 |
Rebecca Taub
BRD | Director/Board Member | 73 | 2016-06-30 |
Richard Levy
BRD | Director/Board Member | 68 | 2016-08-10 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.63% | +3.40% | - | - | 11.75B | |
| +4.43% | +0.21% | +60.07% | +115.25% | 52.88B | |
| +1.58% | +19.37% | +75.37% | +85.18% | 50.98B | |
| -0.23% | -2.41% | -14.36% | -16.00% | 22.81B | |
| +0.98% | +6.11% | -1.35% | +423.40% | 22.43B | |
| +2.03% | +10.85% | +30.31% | -12.32% | 17.01B | |
| +0.88% | +5.07% | +28.91% | -34.26% | 15.91B | |
| +0.68% | +1.51% | +16.43% | +168.03% | 13.29B | |
| +3.02% | +18.32% | +141.11% | +308.04% | 13.58B | |
| -2.32% | +2.28% | +22.94% | - | 12.56B | |
| Average | +1.17% | +4.89% | +39.94% | +129.66% | 24.61B | |
| Weighted average by Cap. | +1.75% | +4.63% | +45.43% | +120.77% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.5B 1.32B 1.21B 1.13B 2.12B 141B 2.17B 14.55B 5.63B 69.59B 5.62B 5.49B 242B | 2.21B 1.94B 1.79B 1.67B 3.13B 208B 3.2B 21.47B 8.3B 103B 8.28B 8.1B 357B |
| Net income | -199M -175M -161M -151M -282M -18.74B -288M -1.93B -747M -9.24B -745M -729M -32.12B | 310M 273M 252M 235M 441M 29.29B 450M 3.02B 1.17B 14.44B 1.17B 1.14B 50.22B |
| Net Debt | -529M -466M -429M -401M -751M -49.95B -767M -5.15B -1.99B -24.63B -1.99B -1.94B -85.63B | -1.09B -963M -887M -830M -1.55B -103B -1.59B -10.65B -4.12B -50.94B -4.11B -4.02B -177B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-25 | €446.40 | -0.07% | 0 |
| 26-06-24 | €446.70 | -0.42% | 5 |
| 26-06-23 | €448.60 | -0.42% | 0 |
| 26-06-22 | €450.50 | +3.44% | 10 |
| 26-06-19 | €435.50 | -1.14% | 10 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MDGL Stock
- YDO1 Stock
Select your edition
All financial news and data tailored to specific country editions
